A Phase III randomized, double-blind, clinical trial of an investigational hexavalent vaccine given at 2, 4, and 11–12 months
| Autor: | Silfverdal, Sven-Arne, Icardi, Giancarlo, Vesikari, Timo, Flores, Sheryl A., Pagnoni, Marco F., Xu, Jin, Liu, G. Frank, Stek, Jon E., Boisnard, Florence, Thomas, Stéphane, Ziani, Eddy, Lee, Andrew W. |
|---|---|
| Zdroj: | In Vaccine 19 July 2016 34(33):3810-3816 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect